BPC-157 5MG, TB-500 5MG (10MG Total Blend)

BPC-157 5MG, TB-500 5MG (10MG Total Blend)

$123.00

Research indicates that BPC-157 and TB-500, when used together, may enhance wound healing through complementary biochemical pathways. This synergy could potentially accelerate recovery from injuries by promoting tissue repair and reducing inflammation.

Available on backorder

Quantity Discount / Amount Price
3 3% $119.31
5 7% $114.39
10 10% $110.70
Summary
BPC-157 5MG, TB-500 5MG (10MG Total Blend)$123.00
$123.00

Product Usage: This product is designated as a "Novelty Peptide" and is intended solely for specialized applications in controlled settings. It is not intended for any specific biological, therapeutic, or diagnostic use. All information provided on this website is for informational and educational purposes only and should not be construed as guidance for any particular application or usage.

download

BPC-157 5mg, TB-500 5mg Blend are two peptides that have gained significant attention in regenerative medicine and sports performance for their potential healing and recovery properties. While both peptides share some similarities in their effects, they have distinct mechanisms of action and unique benefits. This combination has become popular for its synergistic effects in promoting tissue repair, reducing inflammation, and enhancing overall recovery.

BPC-157 Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

Molecular Formula: C62H98N16O22

Molecular Weight:1419.55 g/mol

CAS Number:137525-51-0


TB-500 Sequence: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser

Molecular Formula: C212H350N560O78S

Molecular Weight: 4963.5 g/mol

CAS Number:77591-33-4

BPC-157

BPC-157, or Body Protection Compound-157, is a synthetic peptide derived from a protein found in human gastric juice. It consists of 15 amino acids and has demonstrated remarkable healing properties across various tissues. BPC-157 is particularly noted for its ability to promote angiogenesis, accelerate wound healing, and protect the gastrointestinal tract. Research has shown its efficacy in treating tendon and ligament injuries, muscle damage, and even certain gastrointestinal disorders. BPC-157 works by modulating the nitric oxide (NO) system and promoting the formation of new blood vessels, which is crucial for tissue repair and regeneration.


TB-500

TB-500, also known as Thymosin Beta-4, is a synthetic version of a naturally occurring 43-amino acid peptide found in virtually all human and animal cells. It plays a vital role in cell structure and function, particularly in tissue repair and regeneration. TB-500 is known for its ability to promote cell migration, reduce inflammation, and upregulate actin, a protein essential for cell structure and movement. It has shown promise in treating various injuries, including muscle tears, ligament sprains, and tendinitis. TB-500 is particularly effective in promoting the formation of new blood vessels and enhancing wound healing.

  1. Tissue Repair: Both peptides have demonstrated significant efficacy in promoting tissue repair, with BPC-157 showing particular promise in gastrointestinal and musculoskeletal healing, while TB-500 excels in muscle and tendon repair.
  2. Angiogenesis: BPC-157 and TB-500 both promote the formation of new blood vessels, which is crucial for healing and recovery. BPC-157 does this primarily through modulation of the VEGF system, while TB-500 upregulates actin.
  3. Anti-inflammatory Effects: Both peptides have shown anti-inflammatory properties, with TB-500 demonstrating a more pronounced effect on systemic inflammation.
  4. Wound Healing: Studies have shown that both peptides accelerate wound healing, with BPC-157 showing particular efficacy in gastrointestinal wound healing.
  5. Synergistic Effects: When combined, BPC-157 and TB-500 have demonstrated enhanced healing properties, potentially due to their complementary mechanisms of action.

  1. Clinical Trials: More extensive human clinical trials are needed to fully evaluate the efficacy and safety of both peptides individually and in combination.
  2. Mechanism of Action: Further research is required to elucidate the precise molecular mechanisms by which these peptides exert their effects.
  3. Optimal Dosing: Studies to determine the most effective dosing strategies for different conditions and patient populations.
  4. Long-term Safety: Extended studies to assess the long-term effects and safety profile of both peptides.
  5. Combination Therapies: Exploration of potential synergistic effects with other therapeutic agents or interventions.

  1. Sikiric, P., et al. (2016). Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current Pharmaceutical Design, 22(14), 1808-1818. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/26876224/
  2. Goldstein, A.L., et al. (2012). Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opinion on Biological Therapy, 12(1), 37-51. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/22074294/
  3. Tkalčević, V.I., et al. (2007). Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression. European Journal of Pharmacology, 570(1-3), 212-221. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/17628536/
  4. Philp, D., et al. (2003). Thymosin β4 promotes angiogenesis, wound healing, and hair follicle development. Mechanisms of Development, 120(12), 1335-1347. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/14623443/
  5. Sikiric, P., et al. (2013). Novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157. Vascular recruitment and gastrointestinal tract healing. Current Pharmaceutical Design, 19(1), 76-83. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/22950504/
BPC-157 and TB-500 represent promising avenues for tissue repair and regeneration. While they share some similarities in their effects, their distinct mechanisms of action make them complementary when used in combination. BPC-157 excels in gastrointestinal and localized musculoskeletal healing, while TB-500 shows broader systemic effects and particular efficacy in muscle and tendon repair. The combination of these peptides may offer enhanced healing properties, potentially providing a more comprehensive approach to injury recovery and tissue regeneration. However, as with all peptide therapies, further research is needed to fully understand their long-term effects and optimal use in clinical settings.